Used as a linker in antibody-drug conjugates (ADCs), enabling targeted delivery of cytotoxic agents to cancer cells. The PAB group acts as a spacer that facilitates efficient release of the drug upon intracellular cleavage, while the Trt-protected lysine allows for controlled synthesis and stability during conjugation. This compound is key in enhancing the therapeutic index of ADCs by improving specificity and reducing off-target effects.